The German Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The German Herald.

Press releases published on October 22, 2026

Oct. 22, 2026

Only 600 Made: Scento's 2026 Advent Calendars Hide the 6 Perfumes Europe Ordered Most

Indeterminate EIN Presswire

Oct. 22, 2026

Partner IAM: Identitäten über Unternehmensgrenzen hinweg sicher steuern

Indeterminate EIN Presswire

Oct. 22, 2026

Burckhardt Compression erhält Aufträge für Wasserstoffanwendungen in der Halbleiterindustrie

Indeterminate EIN Presswire

Oct. 22, 2026

Five Reputable Agricultural Component Parts Companies in China 2026: Advancing Farm Machinery

Indeterminate EIN Presswire

Oct. 22, 2026

The Exam Questions Offers Online Scenario-Based Questions and PDF Practice Resources for SAP C_C4H27_2609 Certification

Indeterminate EIN Presswire

Oct. 22, 2026

Childhood Encounter With Death Leads Nicole Briggs-Gary to Help Families Navigate Life's Final Moments

Indeterminate EIN Presswire

Oct. 22, 2026

Peec AI launches Peec Agent and expands actions so marketing teams can act on what AI search says about their brand

Indeterminate GlobeNewswire

Oct. 22, 2026

One04 Therapeutics presents positive interim Phase 1 data for CPV-104 in C3 glomerulopathy in ASN Kidney Week late-breaker

Indeterminate GlobeNewswire

Oct. 22, 2026

InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Five Reputable Mica Insulation Manufacturers in China 2026: Advancing Thermal Protection

Indeterminate EIN Presswire

Oct. 22, 2026

Innovation Defender: HONTA Fortifies Multiwire Drawing Machine Brand Moat with IP & Global Compliance

Indeterminate EIN Presswire

Oct. 22, 2026

Top 10 Reputable Coating Machine Suppliers in China 2026: Advancing Quality and Reliability

Indeterminate EIN Presswire

Oct. 22, 2026

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development

Indeterminate GlobeNewswire

Oct. 22, 2026

BioNTech treibt klinische Phase-3-Studie zu Pumitamig mit Gileads gegen TROP2-gerichtetem Antikörper-Wirkstoff-Konjugat Sacituzumab Govitecan bei Dreifach-Negativem Brustkrebs voran

Indeterminate GlobeNewswire

Oct. 22, 2026

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

Oct. 22, 2026

Hertz Kompressoren brachte sein weltweites Vertriebsnetzwerk beim Internationalen Vertriebstreffen 2026 zusammen

Indeterminate GlobeNewswire

Oct. 22, 2026

Hertz Kompressoren réunit son réseau mondial de distributeurs à l’occasion de l’International Distributor Meeting 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

NexFabric Debuts Human-Verified Industrial AI for Laser Cutting at EuroBLECH 2026

Indeterminate GlobeNewswire